CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 5,000 shares at $3.10 ($15,500)
- 4 Open-market buy Chief Financial Officer bought 3,500 shares at $3.05 ($10,658)
- 4 Open-market buy Chief Medical Officer bought 3,500 shares at $5.10 ($17,850)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $5.08 ($15,240)
- 4 Open-market buy Executive Chairman bought 10,000 shares at $5.03 ($50,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy PFO and PAO bought 1,500 shares at $9.85 ($14,775)
Page 6 of 16 · 313 filings